Skip to main content
Log in

β-thromboglobulin and fibrinopeptide a in diabetes mellitus as markers of vascular damage

  • Original Contributions
  • Published:
Acta diabetologia latina Aims and scope Submit manuscript

Summary

β-thromboglobulin (BTG) and fibrinopeptide A (FpA) were studied in 68 non-insulin dependent diabetic patients (NIDD) aged 32–81 with a mean duration of diabetes of 9±0.8 SEM years and 44 healthy controls, comparable for age and sex. Diabetic patients were subdivided into subsets according to the presence of microvascular disease, macrovascular disease or the absence of these lesions. Patients with microangiopathy (micro- and/or macrovascular disease) had higher HbA (p<0.01), higher blood pressure (p<0.05) than both healthy controls and uncomplicated diabetics. Plasma BTG was higher in diabetic patients than in healthy controls (p<0.02), and was higher in complicated than in non-complicated diabetic subjects. Fpa was higher in complicated than in non-complicated diabetes (p<0.05). No differences were observed between the two subsets of complicated patients. In conclusion, we have shown that increased plasma- and platelet-BTG levels are present in non-insulin dependent diabetic subjects, with normal renal function and that plasma BTG is higher in patients with than in those without vascular disease. Fibrinopeptide A, a sensitive marker ofin vivo fibrin formation, was significantly increased in NIDD with vascular complications.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Babson H. L., Shapiro P. O., Phillips G. E.: A new assay for cholesterol esters which is not affected by bilirubin — Clin. chim. Acta7, 800–804, 1962.

    Article  PubMed  CAS  Google Scholar 

  2. Betteridge D. J., Zahavi J., Jones N. A. G., Shine B., Kakkar V. V., Galton D. J.: Platelet function in diabetes mellitus in relationship to complications, glycosylated haemaglobin and serum lipoproteins — Europ. J. clin. Invest.11, 273–277, 1981.

    PubMed  CAS  Google Scholar 

  3. Borsey D. Q., Dawes J., Fraser D. M., Prowse C. V., Elton R. A., Clarke B. F.: Plasma beta-thromboglobulin in diabetes mellitus — Diabetologia18, 353–357, 1980.

    PubMed  CAS  Google Scholar 

  4. Brooks A. M. V., Hussein S., Chesterman C. N., Martin J. F., Alford F. P., Penington D. G.: Platelets, coagulation and fibrinolysis in patients with diabetic retinopathy — Thrombos. Haemost.43, 123–127, 1983.

    Google Scholar 

  5. Burnstein M., Scholy K. H. R., Morfin R.: Rapid method for the isolation of lipoproteins from human serum by precipitations with polyanions — J. Lipid Res.11, 583–595, 1970.

    Google Scholar 

  6. Burrows A. W.: Beta-thromboglobulin in diabetes: relationships with blood glucose and fibrinopeptide A. In:Standl E., Mehnert H. (Eds): Pathogenetic concepts of diabetic microangiopathy. Internat. Workshop Garmisch-Grainau 1980. Georg Thieme Verlag, Stuttgart-New York, 1981; p. 22.

    Google Scholar 

  7. Burrows A. W., Chavin S. I., Hockaday T. D. R.: Plasma-thromboglobulin concentrations in diabetes mellitus — Lanceti, 225–237, 1978.

    Google Scholar 

  8. Campbell I. W., Dawes J., Fraser D. M., Pepper D. S., Clarke B. F., Duncan L. J. P., Cash J. D.: Plasma β-thromboglobulin in diabetes mellitus — Diabetes26, 1175–1177, 1977.

    Article  PubMed  CAS  Google Scholar 

  9. Colwell J. A., Sagel J., Crook L., Chambers A., Laimins M.: Correlation of platelet aggregation, plasma factor activity and megathrombocytes in diabetic subjects with and without vascular disease — Metabolism26, 279–285, 1977.

    Article  PubMed  CAS  Google Scholar 

  10. Eggstein M.: Eine neue Bestimmung der Neutralfette in Blutserum und Gewebe — Klin. Wschr.44, 273–277, 1966.

    Article  Google Scholar 

  11. Franchi F., Canciani M. T., Mannucci P. M.: The β-thromboglobulin test — Thrombos. Haemost.44 (2), 107, 1980.

    CAS  Google Scholar 

  12. Jones R. L., Peterson C. M.: Haematologic alterations in diabetes mellitus — Amer. J. Med.70, 339–352, 1983.

    Article  Google Scholar 

  13. Kynoch P. A. M., Lehman H.: Rapid estimation (2 1/2 h) of glycosylated haemoglobin for routine purposes — Lancetii, 16, 1977.

    Article  Google Scholar 

  14. Ludlam C. A., Bolton A. E., Moore S., Cash J. D.: New rapid method for diagnosis of deep venous thrombosis — Lancetii, 259–261, 1975.

    Article  Google Scholar 

  15. Ludlam C. A., Cash J. D.: Studies on the liberation of β-thromboglobulin from human plateletsin vitro — Brit. J. Haematol.33, 239–247, 1976.

    CAS  Google Scholar 

  16. Ludlam C. A., Moore S., Bolton A. E., Pepper D. S., Cash J. D.: The release of a human platelet specific protein measured by radioimmunoassay — Thrombos. Res.6, 543–548, 1975.

    Article  CAS  Google Scholar 

  17. Margonato A., Vicari A. M., Vicedomini G., Petrelli P., Pozza G.: Plasma beta-thromboglobulin in uncomplicated insulin-dependent diabetes at rest and during physical exercise — Acta diabetol. lat.20, 27–32, 1983.

    PubMed  CAS  Google Scholar 

  18. Matthews J. H., O’Connor J. F., Hearnshaw J. R., Wood J. K.: Beta-thromboglobulin and glycosylated haemoglobin in diabetes mellitus — Scand. J. Haematol.23, 421–426, 1979.

    Article  PubMed  CAS  Google Scholar 

  19. Nossel H. L., Kaplan K. L., Spanondis K., Soland T., Butler V. P.: The generation of fibrinopeptide A in clinical blood samples — J. clin. Invest.58, 1136, 1976.

    PubMed  CAS  Google Scholar 

  20. Nossel H. L., Yudelman I., Canfield R. E., Butler V. P., Spanondis K., Wilner G. D., Qureshi G. B.: Measurement of fibrinopeptide A in human blood — J. clin. Invest.54, 43, 1974.

    Article  PubMed  CAS  Google Scholar 

  21. Porta M., Peters A. M., Cousins S. A., Cacliero E., Fitzpatrick M. L., Kohner E. M.: A study of platelet-relevant parameters in patients with diabetic microangiopathy — Diabetologia25, 21–25, 1983.

    Article  PubMed  CAS  Google Scholar 

  22. Preston F. E., Ward J. D., Marcola B. H., Porter N. R., Timperley W. R., O’Malley B. C.: Elevated β-thromboglobulin levels and circulating platelet aggregates in diabetic microangiopathy — Lanceti, 238–239, 1978.

    Article  Google Scholar 

  23. Rak K., Beck P., Udwardy M., Pfliegler G., Misz M., Boda Z.: Plasma levels of beta-thromboglobulin and factor VIII-related antigen in diabetic children and adults — Thrombos. Res.29, 155–162, 1983.

    Article  CAS  Google Scholar 

  24. Schernthaner G., Silberbauer K., Sinzinger H., Muller M.: Plasma β-thromboglobulin and glycosylated hemoglobin (HbAi) in type I and type II dabetes mellitus — Thrombos. Haemost.42, 334, 1979.

    Google Scholar 

  25. van Oost B. A., Veldhuyzen B. F. E., van Houwelingen H. C., Timmermans A. P. M., Sixma J. J.: Tests for platelet changes, acute phase reactants and serum lipids in diabetes mellitus and peripheral vascular disease — Thrombos. Haemost.48, 289–293, 1982.

    Google Scholar 

  26. Voisin P. H., Rousselle D., Drovin P., Stoltz J. F.: Beta-thromboglobulin levels in diabetes mellitus: influence of degenerative lesions and glycemic regulation using an artificial pancreas — Thrombos. Res.30, 245–255, 1983.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

This study was supported by the Juvenile Diabetes Foundation Grant N. 184066 and by the National Research Council of Italy,Progetto Finalizzato di Medicina Preventiva e Riabilitativa, Sottoprogetto 4.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Librenti, M.C., D’Angelo, A., Micossi, P. et al. β-thromboglobulin and fibrinopeptide a in diabetes mellitus as markers of vascular damage. Acta diabet. lat 22, 39–45 (1985). https://doi.org/10.1007/BF02591091

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02591091

Key-words

Navigation